Trials / Completed
CompletedNCT00323128
Validation of Serum Creatinine Dosage and Renal Clearance
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- University Hospital, Ghent · Academic / Other
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
This study has an open study design. The GFR will be measured using the renal clearance of inulin (Inutest) in volunteers with different stage of renal disease or without renal disease. A blood sample will be obtained for measuring serum creatinine in different laboratories.
Detailed description
In this study we will investigate the correlation between the GFR as measured by inulin clearance (golden standard) and the estimated GFR as measured by laboratories which used different serum creatinine assays in patients without renal disease and in patients with different stage of kidney failure.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Calculation of inuline clearance | Calculation of inuline clearance. |
| PROCEDURE | Measuring serum creatinine | Measuring serum creatinine. |
Timeline
- Start date
- 2006-05-01
- Primary completion
- 2008-04-01
- Completion
- 2010-12-01
- First posted
- 2006-05-09
- Last updated
- 2011-06-02
Locations
2 sites across 1 country: Belgium
Source: ClinicalTrials.gov record NCT00323128. Inclusion in this directory is not an endorsement.